Effectiveness of an employee skin cancer screening program for secondary prevention.
Incidences of UV-induced skin cancer are continuously increasing. For this reason, early diagnosis is becoming more important. In this study, 783 employees of a technical company participated in an employee skin cancer screening program, which consisted of a physical examination for benign and malignant skin lesions and premalignant conditions. To ensure the quality of the examinations, screening was only performed by 5 trained dermatologists. Participants also were asked to complete a standardized questionnaire prior to examination. A total of 661 skin lesions were diagnosed among 48% of participants; 12.8% of participants exhibited 50 or more melanocytic nevi and the risk for developing skin cancer was categorized as at least moderate for 64.9%. Additionally, 84.4% of participants with at least 1 skin lesion were advised to have a checkup within 1 year. The high rate of suspicious nevi detected in this study suggested that employee skin cancer screening programs are effective and also should be recommended at companies where employees are not at increased risk for developing skin cancer due to the nature of their work (eg, those who work outdoors). Despite the comparatively selective and young study population, these examinations provide evidence of the importance of skin cancer screening for the wider population.
Department of Dermatology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Univeristätsklinikum Erlangen, Germany.
Ugur
U
Uslu
Department of Otorhinolaryngology, Nürnberg Hospital North, Germany.
Felix
F
Hees
Siemens Healthcare GmbH, Erlangen, Germany.
Eva
E
Winnik
Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Univeristätsklinikum Erlangen, Germany.
Wolfgang
W
Uter
Department of Dermatology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Univeristätsklinikum Erlangen, Germany.
Michael
M
Sticherling
D000293:Adolescent; D000328:Adult; D002280:Basal Cell Carcinoma / Q000175:diagnosis*; D000072085:Dermatologists; D055088:Early Detection of Cancer; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D008545:Melanoma / Q000175:diagnosis*; D008875:Middle Aged; D009508:Nevus, Pigmented / Q000175:diagnosis*; D009786:Occupational Health Services; D010808:Physical Examination; D011230:Precancerous Conditions / Q000175:diagnosis*; D055502:Secondary Prevention; D012878:Skin Neoplasms / Q000175:diagnosis*; D055815:Young Adult